Using clinicaltrials.gov, we put together a list of the top 25 rare diseases with the most advanced clinical studies. The aim is to show which therapeutic areas have the lowest attrition rates and which are the closest to launch therapies.

Download the report here:
https://www.terrapinn.com/template/live/engage.aspx?e=6235&d=13544

Diseases were elected based on the following criteria:
– Phase 2b or Phase 3 trials – nearest to market
– Studies with data updates in 2013
– Trials being conducted under FDA surveillance and review
– Sponsored by any types of organizations (NIH, Industry, Research Institutions, Government, Academia, Grants Programs, etc.)

Want to find out which diseases made the list? Download the report now:
https://www.terrapinn.com/template/live/engage.aspx?e=6235&d=13544

For more information on rare disease and orphan drugs, check out World Orphan Drug Congress USA:
https://www.terrapinn.com/2014/world-orphan-drug-congress-usa/

X